SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 107 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,000 | -67.5% | 33,164 | -10.1% | 0.00% | – |
| Q4 2021 | $120,000 | -55.2% | 36,882 | -38.5% | 0.00% | – |
| Q3 2021 | $268,000 | +36.7% | 59,973 | +65.9% | 0.00% | – |
| Q2 2021 | $196,000 | -53.3% | 36,158 | -35.6% | 0.00% | – |
| Q1 2021 | $420,000 | +24.6% | 56,187 | +80.9% | 0.00% | – |
| Q4 2020 | $337,000 | +65.2% | 31,059 | +34.8% | 0.00% | – |
| Q3 2020 | $204,000 | -8.9% | 23,039 | +9.5% | 0.00% | – |
| Q2 2020 | $224,000 | +220.0% | 21,031 | +76.8% | 0.00% | – |
| Q1 2020 | $70,000 | -46.6% | 11,895 | -37.9% | 0.00% | – |
| Q4 2019 | $131,000 | -78.3% | 19,145 | -67.2% | 0.00% | – |
| Q3 2019 | $604,000 | -27.9% | 58,324 | -35.8% | 0.00% | – |
| Q2 2019 | $838,000 | +211.5% | 90,808 | +205.3% | 0.00% | – |
| Q1 2019 | $269,000 | +5.9% | 29,742 | -35.0% | 0.00% | – |
| Q4 2018 | $254,000 | -85.1% | 45,748 | -68.1% | 0.00% | – |
| Q3 2018 | $1,707,000 | -59.1% | 143,501 | -64.9% | 0.00% | -100.0% |
| Q2 2018 | $4,176,000 | +1518.6% | 409,078 | +1951.2% | 0.00% | – |
| Q1 2018 | $258,000 | -3.4% | 19,943 | -27.8% | 0.00% | – |
| Q4 2017 | $267,000 | -48.7% | 27,609 | -22.2% | 0.00% | – |
| Q3 2017 | $520,000 | +122.2% | 35,489 | +141.8% | 0.00% | – |
| Q2 2017 | $234,000 | +1200.0% | 14,679 | +1173.1% | 0.00% | – |
| Q1 2017 | $18,000 | -48.6% | 1,153 | -62.2% | 0.00% | – |
| Q4 2016 | $35,000 | – | 3,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |